$MGRX Phallic Growth Among Small Cap StocksSmall cap stocks have been extremely hot lately and one of them is Mangoceuticals, Inc. (NASDAQ: MGRX) which has been gaining momentum due to a litany of sponsorship deals and its upcoming product launch. These moves reflect MGRX’s thorough understanding of marketing strategy because they precisely
−4.52 USD
−8.71 M USD
615.87 K USD
3.46 M
About Mangoceuticals, Inc.
Sector
Industry
CEO
Jacob D. Cohen
Website
Headquarters
Dallas
Founded
2021
FIGI
BBG01CCMR9Q3
Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company was founded on October 7, 2021 and is headquartered in Dallas, TX.
$MGRX Phallic Growth Among Small Cap StocksSmall cap stocks have been extremely hot lately and one of them is Mangoceuticals, Inc. (NASDAQ: MGRX) which has been gaining momentum since announcing its sponsorship of BarStool Sports’ sex podcast – Only Stans. This move reflects MGRX’s thorough understanding of marketing strategy because it prec
MGRX - Opportunity for Erection Deep Discount IPO price NASDAQ:MGRX - Quiet Period Look for a Re-test of IPO 4 price
Somethings are Better Hard
www.youtube.com
Huge market potential
NASDAQ:MGRX 1.17 Under 13 Mil Market Cap
NYSE:HIMS 2.37 Bil Market Cap
MGRX recent IPO give investors a hard on as it executes its BP
Great marketing and potential i
MGRX Biotechonolgy IPO LONGMGRX a recent IPO produces a med for erectile dysfunction without FDA approval;
They are basically selling a generic version of an approved medication and bypassing
the patent protections and betting they will fly under the regulator radar apparatus.
As might be expeted this recent nano-IPO is hi
MGRX Biotech Penny Stock Pullback for Continuation LONGMGRX with some FDA news catalyst got a lot of action on the last session of the week.
With the pullback and overwhelming volume during the session, a continuation into
the upcoming week is entirely reasonable. ( see also the link)
MGRX had a last price of about $1.50 about a 50% retracement from
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of MGRX is 2.57 USD — it has increased by 22.38% in the past 24 hours. Watch Mangoceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Mangoceuticals, Inc. stocks are traded under the ticker MGRX.
MGRX stock has risen by 46.86% compared to the previous week, the month change is a −31.51% fall, over the last year Mangoceuticals, Inc. has showed a −33.80% decrease.
MGRX reached its all-time high on Mar 21, 2023 with the price of 65.55 USD, and its all-time low was 1.49 USD and was reached on Apr 11, 2025. View more price dynamics on MGRX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MGRX stock is 22.29% volatile and has beta coefficient of 0.28. Track Mangoceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Mangoceuticals, Inc. there?
Today Mangoceuticals, Inc. has the market capitalization of 16.06 M, it has increased by 14.29% over the last week.
Yes, you can track Mangoceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
MGRX net income for the last quarter is −1.95 M USD, while the quarter before that showed −2.00 M USD of net income which accounts for 2.55% change. Track more Mangoceuticals, Inc. financial stats to get the full picture.
No, MGRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 18, 2025, the company has 3 employees. See our rating of the largest employees — is Mangoceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Mangoceuticals, Inc. EBITDA is −7.90 M USD, and current EBITDA margin is −1.28 K%. See more stats in Mangoceuticals, Inc. financial statements.
Like other stocks, MGRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mangoceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mangoceuticals, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mangoceuticals, Inc. stock shows the sell signal. See more of Mangoceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.